Oral Topiramate in Neonates with Hypoxic Ischemic Encephalopathy Treated with Hypothermia: A Safety Study
http://www.jpeds.com/article/PIIS0022347610003197/abstract?rss=yesConclusion
Although the number of newborns in this study was limited, the short-term outcome and the safety data appear to support the evaluation of topiramate in clinical trials to explore its possible additive neuroprotective action.
Interesting. What is the mechanism of action? I will try and find out.
No comments:
Post a Comment